Clorox (CLX) reported fiscal Q2 adjusted earnings late Monday of $1.55 per diluted share, down from $2.16 a year earlier.
Analysts surveyed by FactSet expected $1.40.
Sales for the quarter ended Dec. 31 were $1.69 billion, down from $1.99 billion a year earlier.
Analysts polled by FactSet expected $1.63 billion.
The company expects fiscal year 2025 adjusted earnings of $6.95 to $7.35 per diluted share, compared with its prior outlook of $6.65 to $6.90. Analysts surveyed by FactSet expect $6.86.
The company expects net sales for the year to be down 1% to up 2%, versus its previous outlook for a decline of mid- to high-single digits. Analysts surveyed by FactSet expect $7.05 billion.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。